Key facts
- Obat’s last known valuation is $24.9M (Jun 2025).
- It has raised $19.1M; the latest was Debt - General in Jun 2025.
- Notable investors include Kima Ventures, ISAI, Crédit Mutuel Equity, Holnest, Evolem — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Obat
- ·The full record, as it builds
Funding rounds
No funding rounds for Obat are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Obat
Developer of invoicing and payment software intended to serve small and medium enterprises in the construction industry. The company's platform specializes in estimation, project management, site monitoring, and building craftsmen invoices, enabling clients to focus on their operational business and maximize their value proposition.
- Sector
- Information Technology
- HQ
- Nantes, France
- Founded
- 2019
- Employees
- 80
- Website
- obat.fr/
- Ownership
- Privately Held (backing)
Obat doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Obat shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Obat in its N-PORT filings yet. We sweep new filings monthly.